Skip to content

Depression: all studies

Page 54 of 1,034: studies 531 to 540 of 10,336, newest first. Back to the depression overview

Research

Placebo Effects in the Treatment of Depression-Implications for the Psychedelic Renaissance.

Neurologic Clinics February 1, 2026 Mina Ansari, Sophie I Elliott, Sophie E Holmes et al. 1 citation

The development of novel, rapid-acting treatments and the resurgence of interest in the therapeutic potential of psychedelic-like compounds has stimulated excitement and enthusiasm within the pharmaceutical industry, and provided new hope for millions of individuals suffering with mental illness such as major depressive disorder and post-traumatic stress disorder. This review summarizes the...

The Protective Role of Spirituality, Mindfulness, and Hope in Depression: A Cross-Sectional Study Among Afghan University Students

Journal of Social Sciences and Humanities January 31, 2026 Mohammad Jawad Mirzaee

Depression is highly prevalent among university students worldwide, yet evidence from Afghanistan is limited. This study examined the protective roles of spirituality, mindfulness, and hope against depression among 450 undergraduate and master’s students from four universities in Kabul during the 2025 academic year. The sample was predominantly young adults, with 43.1% aged 18–22 years and...

The Use of Psilocybin in the Treatment of Depressive Disorders: A Narrative Review

Cureus January 31, 2026 Lukasz Siwek, Marta Nowocien, Barbara Balajewicz et al.

Psilocybin is a psychoactive chemical compound that exerts its effects through the activation of serotonergic receptors. It occurs naturally in mushrooms of the genus Psilocybe. Despite its potential medical applications, this substance is regarded as a drug with no recognized medical use. Depression constitutes a psychiatric disorder of substantial global burden, affecting millions of...

Effect of Virtual Reality-Based Mindfulness Program vs Audio-Guided Mindfulness on Depression, Sleep, and Quality of Life in Dementia Family Caregivers: An Exploratory Randomized Controlled Trial.

International Journal of Medical Sciences January 30, 2026

Effect of Virtual Reality-Based Mindfulness Program vs Audio-Guided Mindfulness on Depression, Sleep, and Quality of Life in Dementia Family Caregivers: An Exploratory Randomized Controlled Trial.

Multimodal rapid anti-depression: Esketamine combined with dexmedetomidine patient-controlled sleep for treatment-resistant depression - A retrospective study.

Journal of Affective Disorders January 30, 2026 Yao-Zu Li, Cai-Qun Zhao, Mu-Yan Zuo et al.

To evaluate the efficacy and safety of a multimodal rapid anti-depression therapy that combines esketamine treatment with dexmedetomidine patient-controlled sleep (PCSL) in patients with treatment-resistant depression (TRD). We retrospectively included 233 patients with TRD who received the multimodal treatment. Baseline clinical characteristics were collected. Follow-up assessments were...

Mindful Yoga Therapy For Elderly Depression: Community-Based Nonpharmacological Approach

Gaceta Médica de Caracas January 29, 2026 Wachidah Yuniartika

Introduction: Depression among older adults is a multifaceted public health concern influenced by factors such as spousal loss, social isolation, and biological and psychological changes. Mindful yoga therapy, integrating gentle physical movements with mindfulness practices, offers a non-pharmacological approach to improving mental health in this population.

Single-dose DMT reverses anhedonia and cognitive deficits via restoration of neurogenesis in a stress-induced depression model.

Translational Psychiatry January 29, 2026 Rafael V Lima Da Cruz, Rêmullo B. G. De Miranda Costa, Gabriel M. De Queiroz et al. 2 citations

Major depressive disorder (MDD) remains a leading cause of disability worldwide, with current treatments limited by delayed onset and low efficacy. The serotonergic psychedelic N,N-dimethyltryptamine (DMT) has shown rapid antidepressant effects in early clinical studies, yet its mechanisms and efficacy remain poorly characterized in established models of depression. Here, we evaluated the...

Prophylactic esketamine to reduce postpartum depression in primiparae: A multicentre, double-blind, randomised clinical trial.

European journal of anaesthesiology January 29, 2026 Tiantian Chu, Xiaoling Peng, Keliang Wan et al. 2 citations

Postpartum depression (PPD) is a common complication after childbirth, especially in primiparae. This trial sought to evaluate whether prophylactic administration of esketamine during the perinatal period could prevent PPD in primiparae without predisposition to prenatal depression. A prospective, double-blind, multicentre, randomised controlled trial. Three academic hospitals. Primiparae...

Combining Intranasal Esketamine and Electroconvulsive Therapy in Severe Treatment‑Resistant Depression: A Case Series.

The Journal of ECT January 29, 2026 Sergi López-rodríguez, Aida De Arriba-Arnau, José Manuel Menchón et al. 1 citation

This case series describes the combined use of electroconvulsive therapy (ECT) and intranasal esketamine (ESK)-2 rapidly acting, evidence-based options for treatment-resistant depression (TRD). Each can leave residual symptoms or early relapse. Whether concurrent use confers more durable benefit remains unclear. We followed 4 adults (50 to 72 y) with severe TRD who had shown partial or waning...

Investigating the effectiveness of self-leadership training base on mindfulness on depression, stress, anxiety and ambiguity tolerance of female nursing students in Iran

Psychology and Mental Health Care January 28, 2026 Kianoush Saberi *

Transition to work requires the female students to be compatible with new environments, situations and people that often lead to depression, stress, anxiety and ambiguity. In order to overcome this issue, the concept of mindfulness delivers mental health and welfare notably in depressive and stressful situation as well as feelings of anxiety and concern. Thus, an endeavor in this paper has been...